tiprankstipranks
Shanghai Heartcare Medical Technology Corp. Ltd. Class H (HK:6609)
:6609
Hong Kong Market
Want to see HK:6609 full AI Analyst Report?

Shanghai Heartcare Medical Technology Corp. Ltd. Class H (6609) Ratios

2 Followers

Shanghai Heartcare Medical Technology Corp. Ltd. Class H Ratios

HK:6609's free cash flow for Q2 2025 was ¥0.68. For the 2025 fiscal year, HK:6609's free cash flow was decreased by ¥ and operating cash flow was ¥0.12. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
11.49 11.49 12.42 16.82 16.77
Quick Ratio
9.77 9.74 10.34 14.37 14.81
Cash Ratio
6.23 6.23 7.30 10.41 12.89
Solvency Ratio
0.40 0.66 0.13 -0.49 -1.15
Operating Cash Flow Ratio
0.50 1.63 -0.04 -1.48 -3.95
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 -53.35
Net Current Asset Value
¥ 927.33M¥ 954.13M¥ 879.80M¥ 879.79M¥ 984.94M
Leverage Ratios
Debt-to-Assets Ratio
0.03 0.03 0.03 0.03 0.04
Debt-to-Equity Ratio
0.04 0.04 0.03 0.03 0.04
Debt-to-Capital Ratio
0.04 0.04 0.03 0.03 0.04
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.14 1.14 1.14 1.12 1.13
Debt Service Coverage Ratio
0.00 23.63 11.57 -27.62 -23.28
Interest Coverage Ratio
0.00 21.97 -3.57 -58.35 -92.40
Debt to Market Cap
0.00 0.00 0.00 0.00 <0.01
Interest Debt Per Share
1.11 1.18 0.99 1.01 1.38
Net Debt to EBITDA
-19.85 -10.84 -25.89 8.55 4.90
Profitability Margins
Gross Profit Margin
67.75%69.32%65.39%65.33%67.93%
EBIT Margin
4.12%11.10%-3.69%-43.37%-108.78%
EBITDA Margin
10.59%12.69%7.87%-29.48%-91.41%
Operating Profit Margin
16.15%11.10%-2.24%-54.20%-108.49%
Pretax Profit Margin
17.14%21.16%-4.32%-44.30%-109.95%
Net Profit Margin
17.94%20.41%-4.90%-40.46%-109.48%
Continuous Operations Profit Margin
17.20%20.41%-4.90%-40.46%-109.48%
Net Income Per EBT
104.65%96.44%113.59%91.34%99.57%
EBT Per EBIT
106.16%190.75%192.30%81.74%101.35%
Return on Assets (ROA)
3.61%6.28%-1.13%-7.83%-15.27%
Return on Equity (ROE)
4.22%7.17%-1.28%-8.74%-17.19%
Return on Capital Employed (ROCE)
3.51%3.68%-0.55%-11.03%-15.95%
Return on Invested Capital (ROIC)
3.37%3.53%-0.55%-10.03%-15.74%
Return on Tangible Assets
3.73%6.48%-1.17%-8.15%-15.86%
Earnings Yield
2.63%4.46%-1.75%-9.16%-16.14%
Efficiency Ratios
Receivables Turnover
2.72 4.16 2.85 2.70 6.66
Payables Turnover
3.56 5.18 5.69 21.97 14.21
Inventory Turnover
0.51 0.73 0.56 0.55 0.44
Fixed Asset Turnover
3.21 5.10 2.36 1.68 1.46
Asset Turnover
0.20 0.31 0.23 0.19 0.14
Working Capital Turnover Ratio
0.26 0.41 0.29 0.23 0.16
Cash Conversion Cycle
742.59 514.31 713.37 780.30 850.91
Days of Sales Outstanding
134.13 87.76 128.22 135.16 54.82
Days of Inventory Outstanding
710.96 497.06 649.35 661.75 821.78
Days of Payables Outstanding
102.49 70.51 64.19 16.62 25.69
Operating Cycle
845.09 584.82 777.57 796.92 876.60
Cash Flow Ratios
Operating Cash Flow Per Share
1.23 4.08 -0.09 -2.32 -6.97
Free Cash Flow Per Share
0.99 3.71 -0.22 -3.62 -7.94
CapEx Per Share
0.25 0.37 0.14 1.30 0.97
Free Cash Flow to Operating Cash Flow
0.80 0.91 2.59 1.56 1.14
Dividend Paid and CapEx Coverage Ratio
4.99 10.88 -0.63 -1.79 -7.16
Capital Expenditure Coverage Ratio
4.99 10.88 -0.63 -1.79 -7.16
Operating Cash Flow Coverage Ratio
1.11 3.61 -0.09 -2.43 -5.26
Operating Cash Flow to Sales Ratio
0.18 0.39 -0.01 -0.38 -1.46
Free Cash Flow Yield
2.20%7.68%-1.08%-13.42%-24.48%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
37.96 22.44 -57.16 -10.92 -6.20
Price-to-Sales (P/S) Ratio
6.67 4.58 2.80 4.42 6.79
Price-to-Book (P/B) Ratio
1.56 1.61 0.73 0.95 1.07
Price-to-Free Cash Flow (P/FCF) Ratio
45.55 13.02 -92.80 -7.45 -4.09
Price-to-Operating Cash Flow Ratio
37.21 11.82 -240.76 -11.61 -4.66
Price-to-Earnings Growth (PEG) Ratio
0.02 -0.03 0.67 0.21 0.62
Price-to-Fair Value
1.56 1.61 0.73 0.95 1.07
Enterprise Value Multiple
43.10 25.26 9.72 -6.43 -2.53
Enterprise Value
1.19B 1.27B 212.46M 440.60M 422.48M
EV to EBITDA
43.10 25.26 9.72 -6.43 -2.53
EV to Sales
4.56 3.21 0.76 1.90 2.31
EV to Free Cash Flow
31.19 9.11 -25.32 -3.20 -1.39
EV to Operating Cash Flow
24.94 8.27 -65.69 -4.98 -1.58
Tangible Book Value Per Share
28.30 29.62 26.98 27.00 29.17
Shareholders’ Equity Per Share
29.34 29.99 28.13 28.25 30.45
Tax and Other Ratios
Effective Tax Rate
0.03 0.04 -0.14 0.09 <0.01
Revenue Per Share
6.74 10.53 7.36 6.10 4.78
Net Income Per Share
1.21 2.15 -0.36 -2.47 -5.24
Tax Burden
1.05 0.96 1.14 0.91 1.00
Interest Burden
4.17 1.91 1.17 1.02 1.01
Research & Development to Revenue
0.13 0.08 0.21 0.53 0.84
SG&A to Revenue
0.42 0.46 0.50 0.32 0.39
Stock-Based Compensation to Revenue
<0.01 0.06 0.00 0.05 0.08
Income Quality
1.02 1.78 0.27 0.94 1.33
Currency in CNY